Compare DGICB & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | DGICB | BME |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 565.4M | 547.5M |
| IPO Year | N/A | 2005 |
| Metric | DGICB | BME |
|---|---|---|
| Price | $16.03 | $40.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 697.0 | ★ 36.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.84 | $34.18 |
| 52 Week High | $20.30 | $42.74 |
| Indicator | DGICB | BME |
|---|---|---|
| Relative Strength Index (RSI) | 48.88 | 25.27 |
| Support Level | $15.40 | $39.81 |
| Resistance Level | $17.66 | $40.70 |
| Average True Range (ATR) | 0.31 | 0.60 |
| MACD | -0.09 | -0.27 |
| Stochastic Oscillator | 43.06 | 8.09 |
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.